Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-654-8 | CAS number: 27776-01-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliance and test procedure in accordance with national standard methods (AFNOR norm) with few deviations but no restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: AFNOR T03-021
- Deviations:
- yes
- Remarks:
- The age of animals at study initiation was not reported; individual results (bodyweight, clinical signs) were not reported.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Benzyltoluene
- EC Number:
- 248-654-8
- EC Name:
- Benzyltoluene
- Cas Number:
- 27776-01-8
- Molecular formula:
- C14H14
- IUPAC Name:
- 1-benzyl-2-methylbenzene; 1-benzyl-3-methylbenzene; 1-benzyl-4-methylbenzene
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): Ugilec 101
- Physical state: colourless liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, France
- Age at study initiation: not reported
- Weight at study initiation:
Males: 189 g (mean)
Females: 157 g (mean)
- Fasting period before study: yes, animals without food from 17 to 22 hours before treatment
- Housing: 5/polycarbonate cage (40.8 cm x 33.3 cm x 15 cm)
- Diet: rodent diet ad libitum
- Water (e.g. ad libitum): ad libitum in 500- or 800-mL feeding bottle
- Acclimation period: at least 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 25
- Humidity (%): 50 +/- 20
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES:
The experiments started on April 27, 1981. The sacrifice date of the animals was not reported.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DOSE VOLUME APPLIED:
From 1 to 10 mL/kg
- Doses:
- 0, 2913, 3010, 3107 and 3399 mg/kg administered as 0, 3, 3.1, 3.2, 3.5 mL/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observation; weighing on days 0, 6 and 14
- Necropsy of survivors performed: yes - Statistics:
- Derivation of the DL50 using Litchfield and Wilcoxon method.
Results and discussion
- Preliminary study:
- 10 animals/dose level were administered 1, 5 and 10 mL/kg (equivalent to approximately 971, 4855 and 9710 mg/kg, respectively).
At 1 mL/kg, no animal died, whereas at 5 and 10 mL/kg, all animals died.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 015 mg/kg bw
- 95% CL:
- 2 962 - 3 068
- Mortality:
- Mortality was observed at all tested levels, from 1/10 animals at the first dose level to 10/10 animals at the highest dose level. See table 1 in the field "Remark on results including tables and figures" for further details.
- Clinical signs:
- other: - At the 2913 mg/kg dose level, animals exhibited a slight sedation, 2 to 3 hours after the test substance administration. On day 1, they were prostrated with mid-shut eyes. No additional symptoms were noticed from day 2 and thereafter. - At the 3010
- Gross pathology:
- No abnormalitites were revealed at necropsy.
Any other information on results incl. tables
Table 1 Mortality results
Treatment |
Cumulated Mortality |
|||||
J0 (1 h) |
J0 (3 h) |
J1 |
J4 |
J7 |
J14 |
|
Males |
||||||
Vehicle |
0 |
0 |
0 |
0 |
0 |
0 |
TS at 2913 mg/kg bw |
0 |
0 |
1 |
1 |
1 |
1 |
TS at 3010 mg/kg bw |
0 |
0 |
1 |
2 |
2 |
2 |
TS at 3107 mg/kg bw |
0 |
0 |
4 |
5 |
5 |
5 |
TS at 3399 mg/kg bw |
0 |
0 |
5 |
5 |
5 |
5 |
Females |
||||||
Vehicle |
0 |
0 |
0 |
0 |
0 |
0 |
TS at 2913 mg/kg bw |
0 |
0 |
0 |
0 |
0 |
0 |
TS at 3010 mg/kg bw |
0 |
0 |
3 |
4 |
4 |
4 |
TS at 3107 mg/kg bw |
0 |
0 |
2 |
2 |
2 |
2 |
TS at 3399 mg/kg bw |
0 |
0 |
5 |
5 |
5 |
5 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The LD50 value for the substance was calculated to be 3015 mg/kg in both sexes with a confidence interval (p<0.05) of 2962-3068 mg/kg.
- Executive summary:
The possible acute oral toxicity of BENZYL TOLUENES was evaluated in Sprague-Dawley rats according to the AFNOR guideline #T03-021401 and GLP. In this study, groups of 5 Sprague-Dawley rats/sex/dose were given the substance at 0 to 3.5 mL/kg by gavage. The mortality and general behavior of the animals were observed for a period of 14 days after the administration. The mortality rate was 10%, 60%, 70% and 100% at the dose levels of 3, 3.1, 3.2, 3.5 ml/kg, respectively. Prostration and sedation were observed after treatment. The bodyweight of the animals were not influenced by the treatment. The LD50 was found to be 3.105 ml/kg bw, equivalent to 3015 (2962-3068 mg/kg) mg/kg bw, based on the density of the substance of 0.971 mL/g.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.